Suppr超能文献

影响乳房切除术后植入物重建并发症患者植入物挽救的因素。

Factors Affecting Implant Salvage in Patients with Complications After Post-Mastectomy Implant-Based Reconstruction.

作者信息

Im Kyuseok, Huang Siu-Yuan, Jiangliu Yilan, Yoshinaga Steven, Bai Albert, Chu Michael W, Carre Antoine L, Leung Anna M

机构信息

Department of General Surgery, Kaiser Permanente Los Angeles Medical Center, 4867 W Sunset Blvd, Los Angeles, CA 90027, USA.

Department of Breast Surgery, University of California, 10833 Le Conte Avenue, CHS 77-123, Los Angeles, CA 90095, USA.

出版信息

J Clin Med. 2025 Apr 14;14(8):2682. doi: 10.3390/jcm14082682.

Abstract

: Implant-based reconstruction (IBR) is the most common method of breast reconstruction, but complications lead to patient distress and delays in cancer treatment. Management of implant complications is varied with no defined guidelines. The inability to salvage IBR is associated with infection, but the impact of antibiotics remains controversial. We aimed to analyze factors affecting salvage rates of threatened IBR requiring operative intervention. The primary outcomes were the rates of unplanned re-operation for threatened IBR for wound closure, exchange, or explant. We hypothesized antibiotic administration would improve salvage rates. : A retrospective review of patients undergoing mastectomy with IBR from 2012 to 2023 was performed. Threatened IBR was defined as implant exposure, infection, skin necrosis, hematoma, seroma, or wound dehiscence without implant exposure. Management options for patients with implant infection included implant removal and antibiotic treatment, antibiotic treatment alone, implant replacement, washout and implant replacement, or implant removal without a salvage attempt. : In total, 6901 patients underwent post-mastectomy IBR, and 184 (2.7%) patients had an unplanned re-operation. A total of 166/184 patients (90.2%) underwent explantation, and 18/184 (9.8%) patients had implant salvage. Between the explant and salvage groups, there were no differences in patient demographics, oncologic treatments, or operative characteristics. The explant group had a higher rate of infection (77.7% vs. 22.2%, < 0.0001). There was no difference in culture positivity or antibiotic administration history. : Implant salvage is feasible but limited by infection. Antibiotic administration does not improve salvage rates. Patient factors, oncologic treatment factors, or operative factors do not impact the ability to salvage.

摘要

基于植入物的乳房重建(IBR)是最常见的乳房重建方法,但并发症会给患者带来痛苦,并导致癌症治疗延迟。植入物并发症的处理方式多样,尚无明确的指导方针。无法挽救IBR与感染有关,但抗生素的作用仍存在争议。我们旨在分析影响需要手术干预的濒危IBR挽救率的因素。主要结局是因伤口闭合、更换或取出而对濒危IBR进行的非计划再次手术率。我们假设使用抗生素会提高挽救率。

对2012年至2023年接受IBR乳房切除术的患者进行了回顾性研究。濒危IBR定义为植入物暴露、感染、皮肤坏死、血肿、血清肿或无植入物暴露的伤口裂开。植入物感染患者的处理选项包括取出植入物并进行抗生素治疗、仅进行抗生素治疗、更换植入物、冲洗并更换植入物或不尝试挽救而取出植入物。

共有6901例患者接受了乳房切除术后的IBR,184例(2.7%)患者进行了非计划再次手术。共有166/184例患者(90.2%)进行了植入物取出,18/184例(9.8%)患者的植入物得以挽救。在取出组和挽救组之间,患者人口统计学、肿瘤治疗或手术特征方面没有差异。取出组的感染率更高(77.7%对22.2%,<0.0001)。培养阳性率或抗生素使用史没有差异。

植入物挽救是可行的,但受感染限制。使用抗生素并不能提高挽救率。患者因素、肿瘤治疗因素或手术因素不会影响挽救能力。

相似文献

3
Salvage of Implant-Based Breast Reconstruction in Nipple-Sparing Mastectomies With Autologous Flaps.
Aesthet Surg J. 2018 Jun 13;38(7):734-741. doi: 10.1093/asj/sjx247.
4
The infected or exposed breast implant: management and treatment strategies.
Plast Reconstr Surg. 2004 May;113(6):1634-44. doi: 10.1097/01.prs.0000117194.21748.02.
5
Comparison of Outcomes in Immediate Implant-Based Breast Reconstruction Versus Mastectomy Alone.
Plast Surg (Oakv). 2018 Feb;26(1):18-25. doi: 10.1177/2292550317731764. Epub 2017 Sep 21.
8
A 30-day risk assessment of mastectomy alone compared to immediate breast reconstruction (IBR).
J Plast Surg Hand Surg. 2014 Jun;48(3):209-15. doi: 10.3109/2000656X.2013.865633. Epub 2013 Dec 16.
10
Acellular dermal matrices as an adjunct to implant breast reconstruction: Analysis of outcomes and complications.
Eur J Surg Oncol. 2020 Apr;46(4 Pt A):511-515. doi: 10.1016/j.ejso.2019.10.042. Epub 2019 Nov 1.

本文引用的文献

1
Risk Prediction of Implant Loss following Implant-Based Breast Reconstruction: A Population-Based Study.
Plast Reconstr Surg. 2025 Jul 1;156(1):1e-10e. doi: 10.1097/PRS.0000000000011929. Epub 2024 Dec 17.
2
Reconstructing Failure: Assessing Surgical and Patient-Reported Outcomes after Loss of Initial Breast Reconstruction.
Plast Reconstr Surg. 2025 Apr 1;155(4):649e-659e. doi: 10.1097/PRS.0000000000011717. Epub 2024 Sep 4.
3
Comparative dosimetric study of h-IMRT and VMAT plans for breast cancer after breast-conserving surgery.
Transl Oncol. 2024 Sep;47:102012. doi: 10.1016/j.tranon.2024.102012. Epub 2024 Jun 17.
4
Reconstructive breast implant-related infections: Prevention, diagnosis, treatment, and pearls of wisdom.
J Infect. 2024 Aug;89(2):106197. doi: 10.1016/j.jinf.2024.106197. Epub 2024 Jun 13.
5
Impact of post-operative infection on revision procedures in breast reconstruction: A marketscan database analysis.
J Plast Reconstr Aesthet Surg. 2024 Jun;93:103-110. doi: 10.1016/j.bjps.2024.04.031. Epub 2024 Apr 15.
6
Management of Biofilm with Breast Implant Surgery.
Plast Reconstr Surg. 2023 Nov 1;152(5):919e-942e. doi: 10.1097/PRS.0000000000010791. Epub 2023 Oct 23.
7
Regina Elena Institute (R.E.I.) Protocol for Breast Implant Salvage: Preliminary Results.
Clin Breast Cancer. 2024 Jan;24(1):65-71. doi: 10.1016/j.clbc.2023.09.015. Epub 2023 Sep 29.
8
Oral Antibiotics Do Not Prevent Infection or Implant Loss after Immediate Prosthetic Breast Reconstruction.
Plast Reconstr Surg. 2023 May 1;151(5):730e-738e. doi: 10.1097/PRS.0000000000010073. Epub 2022 Dec 19.
9
Surgical complications in immediate and delayed breast reconstruction: A systematic review and meta-analysis.
J Plast Reconstr Aesthet Surg. 2022 Nov;75(11):4085-4095. doi: 10.1016/j.bjps.2022.08.029. Epub 2022 Aug 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验